Skip to content

AgeBeacon Evidence

Inspect the evidence behind the claims.

AgeBeacon is built to answer a deceptively simple question: what has actually been tested in humans, and what happened? We keep research volume, efficacy, safety and certainty separate so an interesting field does not automatically become an effective intervention.

Scientific Evidence Profiles

Inspect outcomes, populations, effect estimates, certainty and original sources independently of the reader overview. Profiles and public explanations follow the same source evidence.

All 31 tracked topics have a profile entrance. A profile can show reviewed outcomes, a reviewed synthesis or an explicitly pending outcome review. A page existing does not mean its scientific review is complete.

Evidence coverage & review status

Tracked topics, reviewed outcomes and release membership are different measures. Available results do not mean the scientific review is complete or that benefit has been established.

Loading scientific evidence…

An absent reviewed outcome is unresolved, not a neutral result or a statement that no research exists. A source assessment date does not certify a complete literature or safety review. The exercise trial-only fields do not count the separate synthesis literature.

Scientific release history

Published and superseded releases reported by the scientific pipeline. These are dataset releases, separate from website updates and research-depth scoring versions. The current outcome views do not identify their release membership; this history does not assign them a version.

Loading scientific evidence…

Recently recorded evidence →

Methods & evidence trail

From study registration to result

1

Find the human study

We start with clinical-trial registries and source records, not headlines. A study being registered means research exists; it does not mean the intervention works.

2

Decide whether it is actually about healthy aging

Trials are separated into direct longevity relevance, indirect age-related relevance and other research. A disease study or a large trial count is not automatically longevity evidence.

3

Connect results to the trial

Registry results and publications are linked back to the study they describe. Candidate papers are not counted as supportive evidence until that connection and the reported outcomes are verified.

4

Read what happened

Outcomes are interpreted individually as beneficial, neutral, harmful, mixed or unknown only where the available data support that classification. Unknown is never converted into neutral.

5

Assess study quality and context

Randomization, masking, population, sample size, comparator and other design features affect how confidently a result can be interpreted. Statistical significance alone is not treated as clinical importance.

6

Keep safety separate

Adverse events and safety signals are considered independently from efficacy. Sparse safety reporting is treated as insufficient information, not reassurance.

7

Show the evidence status

AgeBeacon reports research depth and confidence without turning research activity into a promise of benefit. Evidence can remain unresolved, and assessments can change when new results appear.

Different outcomes answer different questions

Feeling better, performing better and changing a blood test are different findings. AgeBeacon keeps these outcome families separate. The examples below describe the taxonomy; they do not imply that every outcome has reviewed evidence yet.

Feel

What people report experiencing, such as sleep, fatigue or mood.

  • Sleep quality
  • Fatigue
  • Perceived energy
  • Mood
  • Stress
  • Perceived recovery
Function

What people can do, such as walking, lifting or remembering.

  • Strength
  • Physical function
  • Mobility and walking
  • Exercise performance
  • Cognition and memory
Measurements

Laboratory and physiological measurements; changes do not automatically establish health benefits.

  • Glucose and insulin
  • Lipids
  • Blood pressure
  • Body composition
  • NAD-related measures
  • Inflammatory markers
  • Cardiorespiratory fitness (VO₂max)
Clinical outcomes

Disease events, falls and other outcomes that directly affect health.

  • Cardiovascular events
  • Falls
  • Disease events
Aging

Frailty and aging biology. Aging biomarkers remain distinct from healthspan benefits.

  • Frailty
  • Biological-aging measures
  • Senescence markers
Lifespan

Mortality and survival, with observational associations kept separate from intervention effects.

  • Mortality and survival

Broad or uncategorized source outcomes remain unresolved until scientific review establishes their type. A taxonomy label does not change study design, effect size, certainty or the underlying conclusion.

What the numbers mean

Evidence depth

A 0–100 research-depth score summarizes the amount and quality of relevant human research. It is not an efficacy score and does not mean an intervention works.

Results

Posted or published outcomes are interpreted only when the source supports an interpretation. Trial count and publication count are never substitutes for results.

Safety

Safety is displayed independently from benefit. An absence of reported harms can reflect missing or limited data.

Confidence

Confidence reflects how securely the available evidence can be interpreted. Small, indirect, incomplete or poorly linked evidence lowers confidence.

Human evidence is not the whole biology

Animal and mechanistic research can explain why an intervention is scientifically interesting, but it is kept separate from human clinical evidence. Lifespan extension in mice, a cellular mechanism or a biomarker change is not presented as proof of longer human life.

A living evidence record

Clinical research changes. New results appear, publications are linked, corrections happen and interpretations can become more or less certain. AgeBeacon therefore treats evidence as a versioned record rather than a permanent verdict.

Research-depth scoring framework: v1.0-publication-candidate. AgeBeacon is informational and does not provide medical advice.